The four-year partnership is designed to ensure that the rapid advancement of artificial intelligence benefits underserved communities rather than deepening global inequality. The announcement comes at a time when concerns continue to grow over AI’s potential impact on jobs, economic gaps, and digital exclusion.
Under the agreement, Anthropic will contribute through technical support from its staff as well as usage credits for its Claude AI platform, while the Gates Foundation will provide grant funding, programme development, and policy expertise.
The latest collaboration follows an earlier $50 million initiative announced in January between the Gates Foundation and OpenAI, which seeks to deploy AI tools across 1,000 African clinics and communities by 2028.
A major priority for the new initiative is improving language accessibility in AI systems, particularly for African languages that remain poorly represented in most global models. Foundation director Janet Zhou said current AI tools struggle with writing and translating many African languages, limiting access for millions of people.
To tackle this, the partnership plans to support better data collection and language labeling projects that will be made publicly available to improve AI systems across the industry.
Another project under consideration involves releasing “knowledge graphs” — structured data systems designed to help AI tools better support teachers and education systems in sub-Saharan Africa and India.
Zhou explained that the emphasis on public goods was partly shaped by concerns from governments and organisations worried about overreliance on proprietary technology platforms.
“The needs of different partners and governments, including some of the fears that they may have around proprietary lock-in and sovereignty,” Zhou said while explaining the motivation behind the initiative.
The partnership will also support medical research efforts using Anthropic’s Claude AI to identify possible drug candidates for diseases such as HPV and preeclampsia — health conditions that experts say have historically received less commercial attention from pharmaceutical companies.
According to Anthropic executive Elizabeth Kelly, the initiative aligns closely with the company’s founding vision of using artificial intelligence for broader societal benefit.
“This announcement is really core to who we are as a company,” Kelly said.
Backed by tech giants including Google and Amazon, Anthropic has rapidly grown into one of the leading AI startups amid increasing global demand for advanced AI and coding tools.